Drug interactions in oncology
- 1 August 2004
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 5 (8), 489-496
- https://doi.org/10.1016/s1470-2045(04)01528-1
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatinCancer Chemotherapy and Pharmacology, 2002
- A Transgenic Mouse Expressing Human CYP4B1 in the LiverBiochemical and Biophysical Research Communications, 2001
- Quantitative Drug Interactions Prediction System (Q-DIPS)Clinical Pharmacokinetics, 2001
- Clinical-Pharmacological Strategies to Assess Drug Interaction Potential During Drug DevelopmentDrug Safety, 2001
- Clinical Pharmacokinetics of Low-Dose Pulse Methotrexate in Rheumatoid ArthritisClinical Pharmacokinetics, 1996
- Antineoplastic Agents Drug Interactions of Clinical SignificanceDrug Safety, 1995
- Pharmacokinetic Drug Interactions with Anticancer DrugsClinical Pharmacokinetics, 1994
- Mitomycin antitumour agents: A review of their physico-chemical and analytical properties and stabilityJournal of Pharmaceutical and Biomedical Analysis, 1986
- Pharmacokinetic Drug Interactions of Commonly Used Anticancer DrugsClinical Pharmacokinetics, 1986